In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Nitro Mack Retard Drug Master File in Korea (Nitro Mack Retard KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Nitro Mack Retard. The MFDS reviews the Nitro Mack Retard KDMF as part of the drug registration process and uses the information provided in the Nitro Mack Retard KDMF to evaluate the safety and efficacy of the drug.
After submitting a Nitro Mack Retard KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Nitro Mack Retard API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Nitro Mack Retard suppliers with KDMF on PharmaCompass.